Veterans Administration Western New York Healthcare System, University at Buffalo, State University of New York, Buffalo, New York, USA
Department of Medicine, University at Buffalo, State University of New York, Buffalo, New York, USA.
mSphere. 2020 Jan 8;5(1):e00850-19. doi: 10.1128/mSphere.00850-19.
Hypervirulent (hvKp) is an emerging pathogen of increasing concern due to its ability to cause serious organ and life-threatening infections in healthy individuals and its increasing acquisition of antimicrobial resistance determinants. Identification of hvKp is critical for patient care and epidemiologic and research studies. Five genotypic markers on the hvKp-specific virulence plasmid can accurately differentiate hvKp from the less virulent classical (cKp) strain, but it is unclear whether the possession of fewer markers accurately predicts the hvKp pathotype. Likewise, the effect, if any, of various antimicrobial resistance factors on the pathogenic potential of hvKp has been incompletely explored. The infection model is often used to assess virulence, but this tool has not been validated. Therefore, levels of lethality of defined hvKp and cKp strain cohorts were compared in and outbred mouse models. The murine model, but not the model, accurately differentiated hvKp from cKp strains. Therefore, isolates in which the pathogenic potential is ambiguous due to an incomplete hvKp biomarker profile, an incomplete pLVPK-like hvKp-specific virulence plasmid, antimicrobial resistance that could decrease biofitness, and/or the lack of a characteristic clinical presentation should be validated in an outbred murine model. These data will assist in determining the minimal genomic content needed for full expression of the hypervirulence phenotype. This information, in turn, is critical for the development of the pragmatic point-of-care testing requisite for patient care and for the performance of epidemiologic and research studies going forward. Hypervirulent (hvKp) is of increasing concern because it can infect individuals in community and health care settings and because such infections are becoming difficult to treat. Identification of hvKp is important for patient care and to track its global spread. The genetic definition of hvKp, which can be used for its identification and the development of diagnostic tests, has not been optimized. Determination of possession of 4 of 5 genes that are present on the hvKp-specific virulence plasmid is highly accurate for identifying hvKp. However, an ongoing issue is whether strains that possess only some of these markers are still hypervirulent. The model and, less commonly, the murine infection model have been used to assess the virulence of these ambiguously identifiable strains. This report demonstrates that the murine model but not the model accurately identifies suspected hvKp strains. This information is critical for the development of diagnostics for patient care and for future research studies.
高毒力 (hvKp) 是一种日益受到关注的病原体,因为它能够在健康个体中引起严重的器官和危及生命的感染,并且越来越多地获得抗微生物药物耐药性决定因素。鉴定 hvKp 对于患者护理以及流行病学和研究研究至关重要。hvKp 特异性毒力质粒上的五个基因型标记物可准确地区分 hvKp 与毒力较低的经典 (cKp) 菌株,但尚不清楚是否仅具有较少标记物就能准确预测 hvKp 病原型。同样,各种抗微生物药物耐药性因素对 hvKp 致病性的影响也尚未完全探索。感染模型通常用于评估毒力,但该工具尚未得到验证。因此,在近交和远交小鼠模型中比较了已定义的 hvKp 和 cKp 菌株群的致死率。与 模型不同,小鼠模型可准确地区分 hvKp 和 cKp 菌株。因此,由于 hvKp 生物标志物谱不完整、缺乏完整的 pLVPK 样 hvKp 特异性毒力质粒、可能降低生物适合度的抗微生物药物耐药性以及/或缺乏特征性临床表现而导致毒力不确定的分离株应在远交小鼠模型中进行验证。这些数据将有助于确定充分表达高毒力表型所需的最小基因组含量。反过来,这对于开发用于患者护理的实用即时护理检测以及进行未来的流行病学和研究研究至关重要。高毒力 (hvKp) 越来越受到关注,因为它可以感染社区和医疗保健环境中的个体,并且此类感染越来越难以治疗。鉴定 hvKp 对于患者护理和跟踪其全球传播非常重要。hvKp 的遗传定义,可用于其鉴定和诊断测试的开发,尚未得到优化。确定存在于 hvKp 特异性毒力质粒上的 5 个基因中的 4 个的存在,对于鉴定 hvKp 非常准确。但是,一个持续存在的问题是,仅具有这些标记物中的一些的菌株是否仍具有高毒力。 模型和较少使用的小鼠感染模型已被用于评估这些难以确定的菌株的毒力。本报告表明,小鼠模型而不是 模型可以准确识别可疑的 hvKp 菌株。这些信息对于开发患者护理的诊断方法以及未来的研究研究至关重要。